龙瑞婷,徐昉,廖晓辉. 线粒体动力学在急性肾损伤中的研究进展[J]. 中国急救医学, 2018, 38(7): 641-644.
Long Rui-ting, Xu Fang, Liao Xiao-hui. The research progress of mitochondrial dynamics in acute kidney injury. Chinese Journal of Critical Care Medicine, 2018, 38(7): 641-644.
[1]Mehta RL, Cerdá J, Burdmann EA, et al. International Society of Nephrology′s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology[J]. Lancet, 2015, 385(9987):2616-2643.
[2]Kaddourah A, Basu RK, Bagshaw SM, et al. Epidemiology of Acute Kidney Injury in Critically Ill Children and Young Adults[J]. N Engl J Med, 2017, 376(1):11-20.
[3]Leung KC, Tonelli M, James MT. Chronic kidney disease following acute kidney injury-risk and outcomes[J]. Nat Rev Nephrol, 2013, 9(2):77-85.
[4]Ishihara N, Otera H, Oka T, et al. Regulation and physiologic functions of GTPases in mitochondrial fusion and fission inmammals[J].Antioxid Redox Signal, 2013, 19(4):389-399.
[5]Ishimoto Y, Inagi R. Mitochondria: a therapeutic target in acute kidney injury[J]. Nephrol Dial Transplant, 2016, 31(7):1062-1069.
[6]Zhan M, Brooks C, Liu F, et al. Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology[J]. Kidney Int, 2013, 83(4):568-581.
[7]Lee H, Smith SB, Yoon Y. The short variant of the mitochondrial dynamin OPA1 maintains mitochondrial energetics and cristae structure[J]. J Biol Chem, 2017, 292(17):7115-7130.
[8]Macdonald PJ, Francy CA, Stepanyants N, et al. Distinct Splice Variants of Dynamin-related Protein 1 Differentially Utilize Mitochondrial Fission Factor as an Effector of Cooperative GTPase Activity[J]. J Biol Chem, 2016, 291(1):493-507.
[9]Bhargava P, Schnellmann RG. Mitochondrial energetics in the kidney[J]. Nat Rev Nephrol, 2017, 13(10):629-646.
[10]Brooks C, Wei Q, Cho SG, et al. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models[J]. J Clin Invest, 2009, 119(5):1275-1285.
[11]Noh MR, Kim KY, Han SJ, et al. Methionine Sulfoxide Reductase A Deficiency Exacerbates Cisplatin-Induced Nephrotoxicity via Increased Mitochondrial Damage and Renal Cell Death[J]. Antioxid Redox Signal, 2017, 27(11):727-741.
[12]Funk JA, Schnellmann RG. Persistent disruption of mitochondrial homeostasis after acute kidney injury[J]. Am J Physiol Renal Physiol, 2012, 302(7):F853-864.
[13]Tang WX, Wu WH, Qiu HY, et al. Amelioration of rhabdomyolysis-induced renal mitochondrial injury and apoptosis through suppression of Drp-1 translocation[J]. J Nephrol, 2013, 26(6):1073-1082.
[14]Cho SG, Du Q, Huang S, et al. Drp1 dephosphorylation in ATP depletion-induced mitochondrial injury and tubular cell apoptosis[J]. Am J Physiol Renal Physiol, 2010, 299(1):F199-206.
[15]Perry HM, Huang L, Wilson RJ, et al. Dynamin-Related Protein 1 Deficiency PromotesRecovery from AKI[J]. J Am Soc Nephrol, 2018, 29(1):194-206.
[16]Xiao X, Hu Y, Quirós PM, et al. OMA1 mediates OPA1 proteolysis and mitochondrial fragmentation in experimental models of ischemic kidney injury[J]. Am J Physiol Renal Physiol, 2014, 306(11):F1318-1326.
[17]Aung LHH, Li R, Prabhakar BS, et al. Knockdown of Mtfp1 can minimize doxorubicin cardiotoxicity by inhibiting Dnm1l-mediated mitochondrial fission[J]. J Cell Mol Med, 2017, 21(12):3394-3404.
[18]Morita M, Prudent J, Basu K, et al. mTOR Controls Mitochondrial Dynamics and Cell Survival via MTFP1[J]. Mol Cell, 2017, 67(6):922-935.